Grand Pharmaceutical Group Limited (0512.HK, "Grand Pharma" or the "Group") announces that the Phase II clinical study for the treatment of sepsis in China of the global innovative drug STC3141, which ...

The primary clinical endpoint of the study was the change in the Sequential Organ Failure Assessment ("SOFA") score (a standard for diagnosing sepsis and assessing disease severity) from baseline ...

Discover the critical indicators medical professionals use to detect kidney damage early, from blood tests and urine analysis ...

It was our seventh consecutive quarter of sequential testing ... Simultaneous pancreas kidney transplants are primarily performed for patients with renal failure and insulin-dependent diabetes ...

Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL, United States Background: The pediatric sequential organ failure assessment (pSOFA) and neonatal SOFA (nSOFA) ...

AstraZeneca’s AZN first-quarter 2025 core earnings of $1.24 per American depositary share (ADS) beat the Zacks Consensus Estimate of $1.10. Core earnings of $2.49 per share rose 21% year over year on ...

Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China ...